| |
| Device | RESTYLANE Injectable Gels |
| Generic Name | Implant, dermal, for aesthetic use |
| Applicant | Q-Med AB Seminariegatan 21 Uppsala SE-752-28 |
| PMA Number | P040024 |
| Supplement Number | S116 |
| Date Received | 07/10/2019 |
| Decision Date | 10/08/2019 |
| Product Code |
LMH |
| Advisory Committee |
General & Plastic Surgery |
| Supplement Type | Real-Time Process |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for reclassification of Impurity C in Lidocaine (HCl) of RESTYLANE Injectable Gels from a Specified Unidentified Impurity to an Unspecified Unidentified Impurity. |